Disseminated intravascular coagulation: A review for the internist

Internal and Emergency Medicine

Volumn 8, Issue 1, 2013, Pages 23-32

  Levi, Marcel ^a   van der Poll, Tom ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Anticoagulants; Coagulation; Disseminated intravascular coagulation; Fibrinolysis; Inflammation; Thrombin; Tissue factor

Indexed keywords

EID: 84873192406     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-012-0859-9     Document Type: Review

References (45)

1. Levi M, Seligsohn U (2010) Disseminated intravascular coagulation. In: Kaushansky K, Lichtman M, Beutler E, Kipps T, Prchal J, Seligsohn U (eds) Williams hematology. McGraw Hill, Philadelphia.
2. Levi M, ten Cate H (1999) Disseminated intravascular coagulation. N Engl J Med 341: 586-592.
3. Levi M (2007) Disseminated intravascular coagulation. Crit Care Med 35: 2191-2195.
4. Levi M, van der Poll T (2010) Inflammation and coagulation. Crit Care Med 38: S26-S34.
5. Fourrier F, Chopin C, Goudemand J, Hendrycx S, Caron C, Rime A, Marey A, Lestavel P (1992) Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest 101: 816-823.
6. Dhainaut JF, Yan SB, Joyce DE, Pettila V, Basson BR, Brandt JT, Sundin D, Levi M (2004) Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. J Thromb Haemost 2: 1924-1933.
7. Levi M, Opal SM (2006) Coagulation abnormalities in critically ill patients. Crit Care 10: 222.
8. Anas AA, Wiersinga WJ, de Vos AF, van der Poll T (2010) Recent insights into the pathogenesis of bacterial sepsis. Neth J Med 68: 147-152.
9. Levi M, de Jonge E, van der Poll T (2001) Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation. Crit Care Med 29(7 Suppl): S90-S94.
10. Esmon CT (2001) Role of coagulation inhibitors in inflammation. Thromb Haemost 86(1): 51-56.
11. Levi M (2002) The imbalance between tissue factor and tissue factor pathway inhibitor in sepsis. Crit Care Med 30: 1914-1915.
12. Lowenberg EC, Meijers JC, Levi M (2010) Platelet-vessel wall interaction in health and disease. Neth J Med 68: 242-251.
13. Osterud B (1998) Tissue factor expression by monocytes: regulation and pathophysiological roles. Blood Coagul Fibrinolysis 9(Suppl 1): S9-S14.
14. Furie B, Furie BC (2004) Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation. Trends Mol Med 10: 171-178.
15. de Jonge E, Friederich PW, Levi M, van der Poll T (2003) Activation of coagulation by administration of recombinant factor VIIa elicits interleukin-6 and interleukin-8 release in healthy human subjects. Clin Diagn Lab Immunol 10: 495-497.
16. Levi M (2010) Disseminated intravascular coagulation: a disease-specific approach. Semin Thromb Hemost 36: 363-365.
17. Seligsohn U (2000) Disseminated intravascular coagulation. In: Handin RI, Lux SE, Stossel TP (eds) Blood: principles and practice of hematology. J. B. Lippingcott, Philadelphia.
18. Keller TT, Mairuhu AT, de Kruif MD, Klein SK, Gerdes VE, ten Cate H, Brandjes DP, Levi M, van Gorp EC (2003) Infections and endothelial cells. Cardiovasc Res 60: 40-48.
19. Gando S, Nakanishi Y, Tedo I (1995) Cytokines and plasminogen activator inhibitor-1 in posttrauma disseminated intravascular coagulation: relationship to multiple organ dysfunction syndrome. Crit Care Med 23: 1835-1842.
20. Levi M (2009) Disseminated intravascular coagulation (DIC) in pregnancy and the peri-partum period. Thromb Res 123: S63-S64.
21. Colman RW, Rubin RN (1990) Disseminated intravascular coagulation due to malignancy. Semin Oncol 17: 172-186.
22. Barbui T, Falanga A (2001) Disseminated intravascular coagulation in acute leukemia. Semin Thromb Hemost 27: 593-604.
23. Fisher DF Jr, Yawn DH, Crawford ES (1983) Preoperative disseminated intravascular coagulation associated with aortic aneurysms. A prospective study of 76 cases. Arch Surg 118: 1252-1255.
24. Isbister GK (2010) Snake bite doesn't cause disseminated intravascular coagulation: coagulopathy and thrombotic microangiopathy in snake envenoming. Semin Thromb Hemost 36: 444-451.
25. Levi M, Meijers JC (2011) DIC: which laboratory tests are most useful? Blood Rev 25: 33-37.
26. Dempfle CE, Borggrefe M (2008) Point of care coagulation tests in critically ill patients. Semin Thromb Hemost 34: 445-450.
27. Toh CH, Samis J, Downey C, Walker J, Becker L, Brufatto N, Tejidor L, Jones G, Houdijk W, Giles A, Koschinsky M, Ticknor LO, Paton R, Wenstone R, Nesheim M (2002) Biphasic transmittance waveform in the APTT coagulation assay is due to the formation of a Ca(++)-dependent complex of C-reactive protein with very-low-density lipoprotein and is a novel marker of impending disseminated intravascular coagulation. Blood 100: 2522-2529.
28. Toh CH (2002) Transmittance waveform of routine coagulation tests is a sensitive and specific method for diagnosing non-overt disseminated intravascular coagulation. Blood Rev 16(Suppl 1): S11-S14.
29. Taylor FBJ, Toh CH, Hoots WK, Wada H, Levi M (2001) Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86: 1327-1330.
30. Toh CH, Hoots WK (2007) The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a five year overview. J Thromb Haemost 5: 604-606.
31. Wada H, Hatada T, Okamoto K, Uchiyama T, Kawasugi K, Mayumi T, Gando S, Kushimoto S, Seki Y, Madoiwa S, Okamura T, Toh CH (2010) Modified non-overt DIC diagnostic criteria predict the early phase of overt-DIC. Am J Hematol 85: 691-694.
32. Wada H, Wakita Y, Nakase T, Shimura M, Hiyoyama K, Nagaya S, Mori Y, Shiku H (1995) Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Mie DIC Study Group. Thromb Haemost 74: 848-852.
33. Gando S, Iba T, Eguchi Y, Ohtomo Y, Okamoto K, Koseki K, Mayumi T, Murata A, Ikeda T, Ishikura H, Ueyama M, Ogura H, Kushimoto S, Saitoh D, Endo S, Shimazaki S (2006) A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit Care Med 34: 625-631.
34. Sawamura A, Hayakawa M, Gando S, Kubota N, Sugano M, Wada T, Katabami K (2009) Application of the Japanese Association for Acute Medicine disseminated intravascular coagulation diagnostic criteria for patients at an early phase of trauma. Thromb Res 124: 706-710.
35. Dhainaut JF, Shorr AF, Macias WL, Kollef MJ, Levi M, Reinhart K, Nelson DR (2005) Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure. Crit Care Med 33: 341-348.
36. Kinasewitz GT, Zein JG, Lee GL, Nazir SR, Taylor FB Jr (2005) Prognostic value of a simple evolving DIC score in patients with severe sepsis. Crit Care Med 33: 221-225.
37. Tromp M, Tjan DH, van Zanten AR, Gielen-Wijffels SE, Goekoop GJ, van den Boogaard M, Wallenborg CM, Biemond-Moeniralam HS, Pickkers P (2011) The effects of implementation of the Surviving Sepsis Campaign in the Netherlands. Neth J Med 69: 292-298.
38. Levi M, Toh CH, Thachil J, Watson HG (2009) Guidelines for the diagnosis and management of disseminated intravascular coagulation. Br J Haematol 145: 24-33.
39. Levi M, Levy M, Williams MD, Douglas I, Artigas A, Antonelli M, Wyncoll D, Janes J, Booth FV, Wang D, Sundin DP, Macias WL (2007) Prophylactic heparin in patients with severe sepsis treated with drotrecogin alfa (activated). Am J Respir Crit Care Med 176: 483-490.
40. Warren BL, Eid A, Singer P, Pillay SS, Carl P, Novak I, Chalupa P, Atherstone A, Penzes I, Kubler A, Knaub S, Keinecke HO, Heinrichs H, Schindel F, Juers M, Bone RC, Opal SM (2001) Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 286: 1869-1878.
41. Afshari A, Wetterslev J, Brok J, Møller AM (2008) Antithrombin III for critically ill patients. Cochrane Database Syst Rev CD005370.
42. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJJ (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344(10): 699-709.
43. Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, Finfer S, GÑrdlund B, Marshall JC, Rhodes A, Artigas A, Payen D, Tenhunen J, Al-Khalidi HR, Thompson V, Janes J, Macias WL, Vangerow B, Williams MD (2012) Drotrecogin Alfa (Activated) in adults with septic shock. N Engl J Med 366: 2055-2064.
44. Thachil J, Toh CH, Levi M, Watson HG (2012) The withdrawal of activated protein C from the use in patients with severe sepsis and DIC. Br J Haematol 157: 493-494.
45. Arul GS, Sacks L, Wolf A, Gargan M, Spicer RD (1998) Protein-C concentrate for meningococcal purpura fulminans. Lancet 351: 988-989.